ArticlePharmaceutics2024

Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune Responses.

Walid M Abdelwahab et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.